Fennec Pharmaceuticals Inc.

FRX.TOTSXHealthcare● Active

$12.44

$-0.28(-2.20%)

Market Cap$355535511

P/E Ratio—

52W High$14.24

52W Low$7.59

Avg Volume1K

Open$12.44

Beta1.08

Cash on Hand Financials Revenue

Fennec Pharmaceuticals Inc. (FRX.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

FRX.TO · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$36.7M▲ +37.9% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$36.7M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+37.9%

vs prior fiscal year

Latest Quarter

$40.1M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$36.7MCash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$36.7MNet Cash Position

Cash vs Debt Ratio

Cash 100%Fennec Pharmaceuticals Inc. cash as % of market cap: 10.33%% · MCap $0BDebt 0%

Fennec Pharmaceuticals Inc. has a net cash position of $36.7M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$36.7M − $0 = +$36.7M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

FRX.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

FRX.TO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$36.7M+37.9%

Dec 31, 2024FY$26.6M+100.7%

Dec 31, 2023FY$13.3M-44.2%

Dec 31, 2022FY$23.8M+12.7%

Dec 31, 2021FY$21.1M-30.5%

FRX.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

FRX.TO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Fennec Pharmaceuticals Inc.YOU

FRX.TO

$36.7M$356M10.3%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Fennec Pharmaceuticals Inc. (FRX.TO) cash on hand as of December 31, 2025 is $36.7M, comprising $36.7M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Fennec Pharmaceuticals Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Fennec Pharmaceuticals Inc. cash reserves or cash position.

Fennec Pharmaceuticals Inc. annual cash on hand history shows increased +37.9% in 2025: increased +37.9% in 2025. Fennec Pharmaceuticals Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Fennec Pharmaceuticals Inc. carries total debt of $0 against cash of $36.7M, resulting in a net cash position of +$36.7M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

FRX.TO cash on hand · 5 questions

As of December 31, 2025, Fennec Pharmaceuticals Inc. (FRX.TO) has $36,721,051 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $36,721,051 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $40,075,606. Data sourced from the annual 10-K filing via FMP.

FRX.TO cash on handFRX.TO cash reservesFRX.TO cash 2025how much cash does FRX.TO have

▸ Source: FMP /balance-sheet-statement · US GAAP · Fennec Pharmaceuticals Inc. · Fennec Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025